ARR in Natalizumab treated patients: Interim results from post-marketing surveillance

YOKOYAMA Kazumasa; SATO Ryusuke; MAKIOKA Daiki; IIZUKA Yukihiko; HASE Masatomo; YAN Ling; TORII Shin'ichi; SAITA Takahiko; SAITA Takahiko

Art

J-GLOBAL ID：201702276527296934 Reference number：17A1296332

ARR in Natalizumab treated patients: Interim results from post-marketing surveillance

ナタリズマブ治療患者におけるARR:市販後調査の中間成績

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=17A1296332&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1296332&from=J-GLOBAL&jstjournalNo=L3036C") }}

Author (9)： , , , , , , , ,
Material：
Volume： 22 Issue： 1 Page： 144 Publication year： 2017
JST Material Number： L3036C ISSN： 0918-936X Document type： Proceedings
Article type：会議録記事 Country of issue： Japan (JPN) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1296332&from=J-GLOBAL&jstjournalNo=L3036C") }}

Drug therapy(=pharmacotherapy)for nervous system diseases , Treatment for immunologic diseases,allergic diseases. , Clinical application of immunotherapeutic agents and blood preparations

, , , ,

Return to Previous Page